glp 1 blue cross blue shield coverage 2026 📢 Two important dates for patients interested in GLP-1 medications: ✓ July 1, – Medicare GLP-1 Bridge Program begins for eligible Medicare Part D Anthem Blue Cross Blue Shield

This is not automatic your prescriber needs to submit a continuity exception request with documentation of your prior treatment

Specialty drugs are the highest-stakes part of your pharmacy benefit

Many countries regulate or negotiate medicine prices at a national level

The rising popularity of GLP-1 receptor agonists like semaglutide and tirzepatide has sparked growing interest among both patients and medical professionals seeking effective solutions for weight loss and metabolic health

1 The findings were significant: Those not taking GLP-1 medications showed significantly more MS disease progression Higher risk of brainstem dysfunction (4.36% risk difference) Higher risk of cerebellar dysfunction (4.54% risk difference) Higher risk of bowel and bladder dysfunction (4.98% risk difference) Research from Johns Hopkins University found that GLP-1 receptor agonists delayed disease onset and reduced severity in animal models of MS

Diab Obes